# Chlorogenic Acid Ameliorate Lipopolysaccharide Induced Intestinal Acute Inflammatory Injury via Inhibiting Cytokines Production and Activating Intestinal Stem Cells

**Authors:** Kejin Li, Lulu Li, Weiwei Huang, Suqiang Wang, Guofeng Tan

PMC · DOI: 10.1002/fsn3.71602 · Food Science & Nutrition · 2026-03-04

## TL;DR

Chlorogenic acid protects the intestines from inflammation by reducing harmful immune responses and supporting stem cells.

## Contribution

This study reveals a new mechanism by which chlorogenic acid alleviates intestinal injury via JAK/STAT pathway inhibition and stem cell preservation.

## Key findings

- Chlorogenic acid preserves intestinal barrier integrity by maintaining tight junction gene expression.
- Chlorogenic acid suppresses pro-inflammatory cytokines and enhances anti-inflammatory cytokines in LPS-induced injury.
- Chlorogenic acid sustains intestinal stem cell activity and inhibits JAK/STAT pathway activation.

## Abstract

Several studies have confirmed that chlorogenic acid (CGA) has beneficial effects on intestinal health. This study aimed to investigate the protective effect and underlying mechanism of CGA in lipopolysaccharide (LPS)‐induced intestinal injured mice. Histological analysis of duodenal epithelial morphology and tight junction‐related gene expression indicated that CGA helps preserve intestinal barrier integrity. Quantitative PCR analysis showed that CGA suppressed the expression of pro‐inflammatory factors including interferon‐γ (Ifn‐γ), interleukin‐7 (Il‐7), tumor necrosis factor‐α (Tnf‐α), and upregulated the anti‐inflammatory cytokines interleukin‐10 (Il‐10) in LPS‐induced enteritis mice. Furthermore, compared to LPS‐treatment mice, CGA supplementation sustained intestinal stem cell (ISCs) activity, including proliferation and differentiation. Additionally, CGA inhibited LPS‐induced activation of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway, as evidenced by a reduction in the expression of Jak2, Jak3, and Stat1. This effect was comparable to that of Tofacitinib, a known JAK/STAT pathway inhibitor. Collectively, these findings suggest that CGA protects intestinal epithelial integrity and alleviates intestinal injury by suppressing inflammatory responses and preserving ISC activity via inhibition of the JAK/STAT signaling pathway.

This study aimed to investigate the protective effect and underlying mechanism of CGA in lipopolysaccharide (LPS)‐induced intestinal injury mice. The findings suggest that CGA alleviates intestinal injury by suppressing inflammatory response and preserving ISCs activity via inhibition of the JAK/STAT signaling pathway. All the results highlight that CGA has the potential to serve as a natural food compound for alleviating intestinal inflammation.

## Linked entities

- **Genes:** IFNG (interferon gamma) [NCBI Gene 3458], IL7 (interleukin 7) [NCBI Gene 3574], TNF (tumor necrosis factor) [NCBI Gene 7124], IL10 (interleukin 10) [NCBI Gene 3586], JAK2 (Janus kinase 2) [NCBI Gene 3717], JAK3 (Janus kinase 3) [NCBI Gene 3718], STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772]
- **Chemicals:** chlorogenic acid (PubChem CID 1794427), Tofacitinib (PubChem CID 9926791)
- **Diseases:** enteritis (MONDO:0043579)

## Full-text entities

- **Genes:** Lgr5 (leucine rich repeat containing G protein coupled receptor 5) [NCBI Gene 14160] {aka FEX, Gpr49}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, IL7 (interleukin 7) [NCBI Gene 3574] {aka IL-7, IMD130}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, COX8A (cytochrome c oxidase subunit 8A) [NCBI Gene 1351] {aka COX, COX8, COX8-2, COX8L, MC4DN15, VIII}, Jak3 (Janus kinase 3) [NCBI Gene 16453] {aka fae, wil}, Lyz1 (lysozyme 1) [NCBI Gene 17110] {aka Lyz, Lyzf3, Lzp-s}, Il7 (interleukin 7) [NCBI Gene 16196] {aka A630026I06Rik, Il-7, hlb368}, Cdx2 (caudal type homeobox 2) [NCBI Gene 12591] {aka Cdx-2}, IL7R (interleukin 7 receptor) [NCBI Gene 3575] {aka CD127, CDW127, IL-7R-alpha, IL-7Ralpha, IL7RA, IL7Ralpha}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, Jak2 (Janus kinase 2) [NCBI Gene 16452] {aka Fd17}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 100516343], Cldn1 (claudin 1) [NCBI Gene 12737], IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 406188] {aka ECI-6/IKBA, IKBA}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, TLR4 (toll like receptor 4) [NCBI Gene 399541], JAK1 (Janus kinase 1) [NCBI Gene 3716] {aka AIIDE, JAK1A, JAK1B, JTK3}, Muc2 (mucin 2) [NCBI Gene 17831] {aka 2010015E03Rik, MCM, wnn}, Olfm4 (olfactomedin 4) [NCBI Gene 380924] {aka GC1, GW112, Gm296, Gm913, OlfD, pPD4}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Chga (chromogranin A) [NCBI Gene 12652] {aka ChrA, cgA}, Gcg (glucagon) [NCBI Gene 14526] {aka GLP-1, Glu, PPG}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 396610] {aka JNK, JNK1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 100126861] {aka Akt, PKB}, TYK2 (tyrosine kinase 2) [NCBI Gene 7297] {aka IMD35, JTK1}, Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, JAK3 (Janus kinase 3) [NCBI Gene 3718] {aka JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK}, Cldn7 (claudin 7) [NCBI Gene 53624], Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, HMOX1 (heme oxygenase 1) [NCBI Gene 445512] {aka HSP32}, Tyk2 (tyrosine kinase 2) [NCBI Gene 54721] {aka JTK1}, Egf (epidermal growth factor) [NCBI Gene 13645], Stat1 (signal transducer and activator of transcription 1) [NCBI Gene 20846] {aka 2010005J02Rik}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}
- **Diseases:** tuberculosis (MESH:D014376), allergic reactions (MESH:D004342), enteritis (MESH:D004751), bacterial infections (MESH:D001424), IBD (MESH:D015212), tissue injury (MESH:D017695), ulcerative colitis (MESH:D003093), small-intestinal injury (MESH:C538260), fungal infections (MESH:D009181), intestinal diseases (MESH:D007410), colon cancer (MESH:D015179), weight loss (MESH:D015431), cytotoxicity (MESH:D064420), gastrointestinal ulcers (MESH:D014456), infection (MESH:D007239), gastrointestinal discomfort (MESH:D005767), colitis (MESH:D003092), diarrhea (MESH:D003967), ISCs (MESH:C567703), autoimmune diseases (MESH:D001327), bleeding (MESH:D006470), fever (MESH:D005334), acute and chronic diseases (MESH:D000208), injury (MESH:D014947), Inflammation (MESH:D007249), metabolic and cardiovascular disorders (MESH:D024821), neuroinflammation (MESH:D000090862), inflammatory damage (MESH:D018746), tumor (MESH:D009369), Acute Inflammatory Injury (MESH:D020275)
- **Chemicals:** LPS (MESH:D008070), sucrose (MESH:D013395), PFA (MESH:C003043), DSS (MESH:D016264), CGA (MESH:D002726), DAPI (MESH:C007293), SCFA (MESH:D005232), ROS (MESH:D017382), caffeic acid (MESH:C040048), CuSO4 (MESH:D019327), hematoxylin (MESH:D006416), HEPEs (MESH:D006531), DPBS (-), 4,6-diamino-2-phenyl indole (MESH:C000607851), Y27632 (MESH:C108830), H&amp;E (MESH:D006371), celecoxib (MESH:D000068579), 3-hydroxyphenylpropionic acid (MESH:C491266), Phenolic acids (MESH:C017616), TRIzol (MESH:C411644), water (MESH:D014867), adalimumab (MESH:D000068879), GlutaMAX (MESH:C054122), secukinumab (MESH:C555450), EdU (MESH:C022811), Paraffin (MESH:D010232), T (MESH:D014316), ibuprofen (MESH:D007052), Triton X-100 (MESH:D017830), Tofacitinib (MESH:C479163), prostaglandin (MESH:D011453), EDTA (MESH:D004492), N2 (MESH:D009584), F12 (MESH:C007782)
- **Species:** Homo sapiens (human, species) [taxon 9606], Sus scrofa (pig, species) [taxon 9823], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C0081S, C +- 2 C, CGA at 0

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12958132/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12958132/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12958132/full.md

---
Source: https://tomesphere.com/paper/PMC12958132